Obesity
From the Journals
Bariatric surgery may curtail colorectal cancer risk
Conference Coverage
Obesity expert: Time to embrace growing array of options
MAUI, HAWAII - "Gastroenterologists are in the first line of treatment for obesity management."
News from the FDA/CDC
Lorcaserin withdrawn from U.S. market due to cancer risk
The Food and Drug Administration advised health care professionals to stop prescribing and dispensing lorcaserin and to contact patients who are...
Conference Coverage
Score predicts surgery’s benefits for obesity, diabetes
†obesity
LAS VEGAS –
From the Journals
Liver fibrosis scores predict CV event risk associated with NAFLD
NAFLD is associated with a twofold increase in cardiovascular events, and liver fibrosis in NAFLD is associated with a fourfold increase.
Latest News
Fewer interventions after sleeve gastrectomy vs. Roux-en-Y, real-world data show
Balanced by weight loss and health outcomes data, safety results may help inform decision making for prospective patients and physicians,...
News
FDA warns of possible cancer risk with lorcaserin
Results from a clinical trial assessing the drug’s safety showed the possible risk increase.
Conference Coverage
Evidence builds for bariatric surgery’s role in cancer prevention
LAS VEGAS – Some patients are trying to reduce their future risk for cancer with the procedure.
Conference Coverage
Nearly 25% of U.S. adults take an obesogenic prescription drug
The 2013-2016 analysis also showed a strong link between obesogenic drug use and increasing obesity severity.
Latest News
Bariatric surgery shows metabolic benefits in lower-BMI patients
LAS VEGAS – Data from 45,000 patients showed that those who had a BMI below 35 kg/m2 benefited as much as those with higher BMIs.